SAR-442257
SAR442257 is a humanized IgG4-S228P, kappa monoclonal antibody targeting CD38 and CD28 on multiple myeloma cells and co-stimulates CD3 and CD28 on T cells[1].
Product Specifications
UNSPSC
12352203
Target
CD28; CD3; CD38
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.0
Smiles
[*]S[R442257]
Molecular Weight
(145.44 kDa)
References & Citations
[1]Grab AL, et al. Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma. Cells. 2024 May 20;13 (10) :879.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Napsin A Antibody (rNAPSA/7239) [DyLight 755]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
307869-01 50 µL
CNDP1 (Carnosine Dipeptidase 1, CN1, CPGL2, HsT2308, Glutamate carboxypeptidase-like protein 2, Beta-Ala-His dipeptidase)
Ask
View Details 307869-02 100 µL
CNDP1 (Carnosine Dipeptidase 1, CN1, CPGL2, HsT2308, Glutamate carboxypeptidase-like protein 2, Beta-Ala-His dipeptidase)
Ask
View Details NBP1-51847B 1 mL
Donkey Polyclonal Donkey anti-Human IgG (H+L) Secondary Antibody [Biotin]
Ask
View Details